Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitofusin-1 (MFN1) is a mitochondrial outer membrane GTPase essential for the process of mitochondrial fusion and maintenance of mitochondrial network morphology[3][4]. Along with its paralog mitofusin-2 (MFN2), it mediates the tethering and subsequent fusion of the outer membranes of adjacent mitochondria through GTP-dependent oligomerization and conformational changes[1][2][4]. Structurally, MFN1 contains an N-terminal GTPase domain, a transmembrane domain that anchors it in the outer mitochondrial membrane, and two heptad repeat coiled-coil domains (HR1 and HR2) critical for membrane tethering and fusion[1][2][4]. By regulating mitochondrial morphology, MFN1 influences important cellular processes such as energy production, apoptosis, cell proliferation, and signaling[1][2][3][4]. Both loss and gain of MFN1 function are linked to pathological conditions including neurodegenerative disorders and cardiovascular disease, highlighting its role as a potential therapeutic target[2][4][5]. Small molecules such as MASM7 have been identified that can activate MFN1, promoting mitochondrial fusion, serving as potential tools for modulating mitochondrial dynamics in disease contexts[2].
Activation or inhibition of mitochondrial fusion via direct modulation of MFN1 oligomerization and conformational state[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitofusin-1 (MFN1).